Validity and Reliability of the Turkish Version of the Coronary Artery Disease Education Questionnaire-II (CADEQ-II)

2021 ◽  
Vol 12 (27) ◽  
pp. 26-35
Author(s):  
Esra Akbulut ◽  
◽  
Burcu Bayrak Kahraman ◽  
2013 ◽  
Vol 77 (2) ◽  
pp. 424-431 ◽  
Author(s):  
Naoki Nakayama ◽  
Kiyoshi Hibi ◽  
Mitsuaki Endo ◽  
Akiyoshi Miyazawa ◽  
Hiroyuki Suzuki ◽  
...  

2019 ◽  
Vol 25 (1) ◽  
Author(s):  
Cristiane de Fátima Travensolo ◽  
Juliano Ferreira Arcuri ◽  
Marcos Doederlein Polito

2021 ◽  
pp. 105477382110033
Author(s):  
Jiyoung Kim ◽  
Nayeon Shin ◽  
Kyungmi Lee

The study aimed to develop and test the Coronary Artery Disease Empowerment Scale in Korea and assess its initial aspects of validity and reliability. The participants included 301 patients diagnosed with coronary artery disease, receiving regular outpatient and inpatient care. Data were collected from August to December 2019. The exploratory factor analysis resulted in extracting 25 items and three factors—self-determination, emotional self-regulation, and personal competence of disease management perception—with a cumulative explanatory power of 55.40%. A significant correlation was found between the Korean versions of the Cardiac Self-efficacy Scale ( r = .31, p < .001) and the Health Empowerment Scale ( r = .45, p < .001). The internal consistency reliability of all items was .93. The developed instrument can be used to evaluate empowerment in patients with coronary artery disease and identify an improved instrument to measure empowerment. However, further testing of the newly developed Coronary Artery Disease Empowerment Scale is required.


2010 ◽  
Vol 4 (2) ◽  
pp. 57-63 ◽  
Author(s):  
Satomi Seki ◽  
Naoko Kato ◽  
Naomi Ito ◽  
Koichiro Kinugawa ◽  
Minoru Ono ◽  
...  

2019 ◽  
Vol 133 (22) ◽  
pp. 2283-2299
Author(s):  
Apabrita Ayan Das ◽  
Devasmita Chakravarty ◽  
Debmalya Bhunia ◽  
Surajit Ghosh ◽  
Prakash C. Mandal ◽  
...  

Abstract The role of inflammation in all phases of atherosclerotic process is well established and soluble TREM-like transcript 1 (sTLT1) is reported to be associated with chronic inflammation. Yet, no information is available about the involvement of sTLT1 in atherosclerotic cardiovascular disease. Present study was undertaken to determine the pathophysiological significance of sTLT1 in atherosclerosis by employing an observational study on human subjects (n=117) followed by experiments in human macrophages and atherosclerotic apolipoprotein E (apoE)−/− mice. Plasma level of sTLT1 was found to be significantly (P<0.05) higher in clinical (2342 ± 184 pg/ml) and subclinical cases (1773 ± 118 pg/ml) than healthy controls (461 ± 57 pg/ml). Moreover, statistical analyses further indicated that sTLT1 was not only associated with common risk factors for Coronary Artery Disease (CAD) in both clinical and subclinical groups but also strongly correlated with disease severity. Ex vivo studies on macrophages showed that sTLT1 interacts with Fcɣ receptor I (FcɣRI) to activate spleen tyrosine kinase (SYK)-mediated downstream MAP kinase signalling cascade to activate nuclear factor-κ B (NF-kB). Activation of NF-kB induces secretion of tumour necrosis factor-α (TNF-α) from macrophage cells that plays pivotal role in governing the persistence of chronic inflammation. Atherosclerotic apoE−/− mice also showed high levels of sTLT1 and TNF-α in nearly occluded aortic stage indicating the contribution of sTLT1 in inflammation. Our results clearly demonstrate that sTLT1 is clinically related to the risk factors of CAD. We also showed that binding of sTLT1 with macrophage membrane receptor, FcɣR1 initiates inflammatory signals in macrophages suggesting its critical role in thrombus development and atherosclerosis.


Sign in / Sign up

Export Citation Format

Share Document